PI Industries Limited share price

Key numbers

Market cap

₹ 36,410 Cr

Current price

₹ 2,400.00

52-week high / low

₹ 3,833 / 2,191

Stock P/E

31.2

Book value

₹ 740.3

Dividend yield

0.63%

ROCE

15.6%

ROE

12.4%

Debt to equity

0.03

Sales growth (3 yrs)

1.1%

Profit growth (3 yrs)

2.4%

1-year return

-33.9%

About PI Industries Limited

PI Industries Limited, together with its subsidiaries, manufactures and distributes of agricultural chemicals in India, rest of Asia, North America, Europe, and internationally. It operates through Agro Chemicals and Pharma segments. The company offers agrochemicals, including insecticides, fungicides, herbicides, and biologicals; crop solutions for soybeans, chili, sugarcane, rice, wheat, cotton, and corn, as well as horticulture products; and plant nutrients and specialty chemicals. It also provides custom synthesis and manufacturing services to other companies; and pharmaceuticals, medicinal chemical, and botanical products. The company sells its products to farmers, distributors, retailers, and sellers. It also exports its products. PI Industries Limited was incorporated in 1946 and is based in Gurugram, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-18)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• While there have been shortages in fertilizer area, our special effort to use biological to support need of the farmer while addressing the need of sustainable vision in agriculture has resulted in achieving positive quarter and aggressive growth of 50% in biological s, and a flat rather than negative outlook.
• Given our unique business model, we remain confident of a positive trajectory for the business over the mid to long term.

Growth & demand

• Biologicals have shown an aggressive growth of 50% with a three- year CAGR of 15%.
• Despite a challenging operating environment in the domestic market, we delivered a 12% volume growth in this quarter, translating into a 3% revenue growth.

Margins & costs

• There are pressure on margins due to high input cost & higher levels of inventory, however we believe consumption patterns will see a positive trajectory.
• 17,023 million with a healthy gross margin of 57% and EBITDA at 22%.

Capex & expansion

• 800 crore, which is the standard capex as you rightly said.
• 550 crore of expenses in pharma, and we are doing more capex in Archimica.

Balance sheet & cash

• We have always believed in disciplined capital allocation and therefore maintain a rigorous focus on net working capital as well.
• Despite the challenging environment, the team delivered an impressive reduction of 19 days in net working capital, releasing INR 300 crore of cash.

Peers in Agricultural Inputs

• Coromandel International Limited
• The Fertilisers and Chemicals Travancore Limited
• UPL Limited
• Sumitomo Chemical India Limited
• Chambal Fertilisers and Chemicals Limited
• Bayer CropScience Limited
• Paradeep Phosphates Limited
• E.I.D.- Parry (India) Limited
• Madhya Bharat Agro Products Limited
• Sharda Cropchem Limited